Related Experiment Video
Updated: Feb 9, 2026
15:53
Cell Death Associated with Abnormal Mitosis Observed by Confocal Imaging in Live Cancer Cells
Published on: August 21, 2013
15.6K
Combined HAT/EZH2 modulation leads to cancer-selective cell death
Francesca Petraglia1, Abhishek A Singh2, Vincenzo Carafa1
1Dipartimento di Medicina di Precisione, Università degli Studi della Campania Luigi Vanvitelli, Napoli 80138, Italy.
Oncotarget
|June 8, 2018
Summary
A novel hybrid epi-drug, MC2884, effectively targets cancer cells by modulating the epigenome and inducing apoptosis. This histone deacetylase inhibitor shows promise for treating various cancers, including aggressive and deficient types, paving the way for personalized medicine.
Area of Science:
- Oncology
- Epigenetics
- Pharmacology
Background:
- Epigenetic alterations are key drivers in cancer pathogenesis and progression.
- Targeting epigenetic mechanisms offers a promising strategy for cancer therapy.
Purpose of the Study:
- To identify and characterize a novel hybrid epi-drug, MC2884, with cancer-selective cell death-inducing properties.
- To elucidate the mechanism of action of MC2884 and evaluate its therapeutic potential in various cancer models.
Main Methods:
- Screening of library compounds to identify MC2884, a HAT/EZH2 inhibitor.
- In vitro, ex vivo, and in vivo xenograft studies to assess anticancer efficacy.
- Epigenome modulation analysis (H3K27me3, H3K27ac, H3K9/14ac) and apoptosis induction studies (caspase-dependent, mitochondrial pathway).
Main Results:
- MC2884 demonstrated cancer-selective cell death in solid and hematological cancers.
- Anticancer effects were mediated by epigenome modulation and caspase-dependent apoptosis, involving downregulation of BCL2.
- MC2884 showed efficacy in aggressive cancer models (p53-/-, TET2-/-) and primary human leukemia blasts.
Conclusions:
- MC2884 represents a novel therapeutic agent with broad anticancer activity.
- The drug's mechanism involves epigenome modulation and BCL2 downregulation, suggesting potential in combination therapies.
- MC2884 coupled with epigenome analysis offers a pathway towards personalized precision medicine in oncology.
Related Concept Videos
01:18Autophagic Cell Death
4.6K
Christian de Duve discovered “autophagy,” a process in which cellular components are engulfed by membrane-bound organelles called autophagosomes. The autophagosomes then fuse with lysosomes to digest the enclosed contents. Autophagy is generally activated in cells to prevent cell death. However, cell death is triggered when the damage is beyond repair.
Autophagy and Apoptosis
Autophagy can activate apoptosis. In normal conditions, the autophagy activating protein Beclin-1 and...
Autophagy and Apoptosis
Autophagy can activate apoptosis. In normal conditions, the autophagy activating protein Beclin-1 and...
4.6K
01:30Overview of Cell Death
10.2K
Cell death is an essential process where the body gets rid of old or damaged cells. Cell proliferation and death need to be balanced, as an imbalance between the two may lead to cancer or autoimmune diseases.
Cell death was observed in the early 19th century, but there was no experimental evidence to prove it. In 1842, Carl Vogt first discovered cell death in a metamorphic toad; however, it was not termed ‘cell death.’ Scientists discovered different cell death pathways only in the...
Cell death was observed in the early 19th century, but there was no experimental evidence to prove it. In 1842, Carl Vogt first discovered cell death in a metamorphic toad; however, it was not termed ‘cell death.’ Scientists discovered different cell death pathways only in the...
10.2K
01:22T Cell Activation and Clonal Selection
16.2K
T cells are integral to our adaptive immune system, recognizing and effectively responding to foreign antigens. T cell activation and clonal selection are pivotal in orchestrating this immune response. This article elucidates these mechanisms, detailing the roles of cluster of differentiation (CD) markers, major histocompatibility complex (MHC) molecules, costimulatory signals, and the process of clonal selection.
Naive T cells that have not yet encountered an antigen express two primary CD...
Naive T cells that have not yet encountered an antigen express two primary CD...
16.2K
01:22Phase-lead and Phase-lag Controllers
574
Understanding the working function of different types of controllers can be illustrated with practical analogies, such as adjusting a stereo's volume equalizer. Cranking up the bass involves a phase-lead controller, which functions as a high-pass filter, while increasing the treble uses a phase-lag controller, which acts as a low-pass filter. PD controllers, similar to high-pass filters, enhance the system's response to high-frequency components. PI controllers, akin to low-pass...
574
01:32What is Natural Selection?
129.6K
Natural selection is an evolutionary process in which individuals with survival-promoting traits reproduce at higher rates. These favorable traits become more common within a population or species. Naturally selected traits initially arise via random genetic mutations. In order for selection to occur, there must be variation within a population, the trait controlling the variation must be heritable, and there must be an evolutionary advantage for variation in the trait.
129.6K
00:57Antibiotic Selection
60.0K
Overview
60.0K